Sign In
Pharma
SII, Bharat Biotech get Rs 4,500 cr supply credit
Bharat Biotech's Covaxin booster dose gets nod for trial, to be administered after second shot
Lancet publishes results of Covaxin phase 2 clinical trials
Markets
Reveal vaccine capacities, Delhi HC tells Bharat Biotech
Covaxin's clinical efficacy at 81%
Right vaccines, masks, social distancing need of the hour
Hyderabad lived up to its tag as vaccine capital, says KTR
Telangana aims to make life sciences a $100 billion industry
Covaxin heads to the US
Bharat Biotech secures a fresh Letter of Comfort from the Centre for 45 lakh doses of Covaxin
Coronavirus: Government is yet to decide on giving indemnity to vaccine makers
Covaxin arrives in Delhi; 20,000 doses to reach Rajiv Gandhi Hospital
